The product is codenamed VR730, and Hikma will be responsible for the clinical development, manufacture and commercialisation of the salmeterol generic, delivered via Vectura's dry powder inhaler.

President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an ...

The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory diseases inhaler ... Sandoz generics arm, and Hikma have tried unsuccessfully to get copies ...

Hikma Pharmaceuticals Usa Inc was founded in 2011 and operates in Eatontown, United States. The company engages in the sector 'Pharmaceuticals, Medicinal Chemical & Botanical Products' (ISIC: 2100 ...

Hikma Pharmaceuticals will acquire parts of Danish firm Xellia Pharmaceuticals, a drug company specialising in injectable ...

Albuterol 90mcg/inh; metered-dose aerosol; contains hydrofluoroalkane; CFC-free. The pharmacological effects of beta 2-adrenoceptor agonist drugs are at least in part attributable to stimulation ...

Inhaler: peak plasma concentrations of 49ng/mL reached within 15 minutes. Nasal spray: maximum venous concentrations of 2–12ng/mL reached in 4–15 minutes. Nasal Spray antagonized by nasal ...

Bronchodilators relax airways and help keep bronchioles open. BRETARIS GENUAIR is a dry powder inhaler that uses your breath to deliver the medicine directly into your lungs. This makes it easier ...

London, United Kingdom – Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group, today provides an update on current trading. Riad Mishlawi, Hikma’s CEO, said: “I am pleased ...

PARIS, FRANCE - AUGUST 24: Inhaler performs during the Rock en Seine Festival on August 24, 2024 in Paris, France. (Photo by Kristy Sparow/Getty Images) Inhaler have suggested that they will be ...

The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could ...